Risk Factors of Ischemic Stroke in Patients With Atrial Fibrillation Post Transcatheter Aortic Valve Implantation From the Randomized ENVISAGE-TAVI AF Trial

In patients with prevalent or incident atrial fibrillation (AF) after successful transcatheter aortic valve implantation (TAVI) enrolled in the ENVISAGE-TAVI AF trial, the incidence of ischemic stroke (IS) and any stroke was numerically lower in the edoxaban group vs. the vitamin K antagonist (VKA) group. The current study aimed to identify risk factors associated with IS in an on-treatment subanalysis of patients from ENVISAGE-TAVI AF who received ≥1 dose of edoxaban or VKA. Baseline …